Characterization of the early steps of human parvovirus B19 infection

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9274-9284

  Quattrocchi, Silva ^a   Ruprecht, Nico ^a   B̈nsch, Claudia ^a   Bieli, Sven ^a,d   Zürcher, Christoph ^a   Boller, Klaus ^b   Kempf, Christoph ^a,c   Ros, Carlos ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b PAUL EHRLICH INSTITUT   (Germany)

^c CSL Behring AG   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; BAFILOMYCIN A1; CAVEOLIN 1; CHLOROQUINE; FLOTILLIN 1; GLOBOSIDE; NYSTATIN; VIRUS DNA;

ACIDIFICATION; ARTICLE; BIOACCUMULATION; CELL MIGRATION; CELL NUCLEUS; CELL PH; COATED VESICLE; CONTROLLED STUDY; DNA DEGRADATION; ENDOCYTOSIS; ENDOSOMAL ESCAPE; ENDOSOME; HUMAN PARVOVIRUS B19; LIPID RAFT; LYSOSOME; MEMBRANE BIOLOGY; MEMBRANE DAMAGE; MOLECULAR DYNAMICS; NONHUMAN; PARVOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS ENTRY; VIRUS INHIBITION; VIRUS TRANSCRIPTION; VIRUS UPTAKE;

CELL LINE; CELL NUCLEUS; ENDOCYTOSIS; ENDOSOMES; ERYTHEMA INFECTIOSUM; GLOBOSIDES; HUMANS; LYSOSOMES; PARVOVIRUS B19, HUMAN; RECEPTORS, VIRUS;

MIRIDAE; PARVOVIRUS;

EID: 84866150475     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01004-12     Document Type: Article

References (64)

1. Bang B, Gniadecki R, Gajkowska B. 2005. Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes. Exp. Dermatol. 14:266-272.
2. Bantel-Schaal U, Braspenning-Wesch I, Kartenbeck J. 2009. Adenoassociated virus type 5 exploits two different entry pathways in human embryo fibroblasts. J. Gen. Virol. 90:317-322.
3. Bartlett JS, Wilcher R, Samulski RJ. 2000. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74:2777-2785.
4. Basak S, Turner H. 1992. Infectious entry pathway for canine parvovirus. Virology 186:368-376.
5. Boisvert M, Fernandes S, Tijssen P. 2010. Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J. Virol. 84:7782-7792.
6. Bolard J. 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864:257-304.
7. Bönsch C, Kempf C, Ros C. 2008. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J. Virol. 82:11784-11791.
8. Bönsch C, et al. 2010. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl. Trop. Dis. 4:e669. doi:10.1371/journal.pntd.0000669.
9. Bönsch C, Zuercher C, Lieby P, Kempf C, Ros C. 2010. The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. J. Virol. 84:11737-11746.
10. Bonvicini F, et al. 2008. HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. J. Gen. Virol. 89:3034-3038.
11. Bowman EJ, Siebers A, Altendorf K. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells. Proc. Natl. Acad. Sci. U. S. A. 85:7972-7976.
12. Brown KE, Anderson SM, Young NS. 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117.
13. Chen AY, Kleiboeker S, Qiu J. 2011. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. PLoS Pathog. 7:e1002088. doi:10.1371/journal.ppat.1002088.
14. Cohen S, Pante N. 2005. Pushing the envelope: microinjection of Minute virus of mice into Xenopus oocytes causes damage to the nuclear envelope. J. Gen. Virol. 86:3243-3252.
15. Cohen S, Behzad AR, Carroll JB, Pante N. 2006. Parvoviral nuclear import: bypassing the host nuclear-transport machinery. J. Gen. Virol. 87:3209-3213.
16. Cossart YE, Field AM, Cant B, Widdows D. 1975. Parvovirus-like particles in human sera. Lancet 11:72-73.
17. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol. 60:548-557.
18. Cotmore SF, Tattersall P. 2007. Parvoviral host range and cell entry mechanisms. Adv. Virus Res. 70:183-232.
19. Das S, Chakraborty S, Basu A. 2010. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J. Neurochem. 115:537-549.
20. Dudleenamjil E, et al. 2010. Bovine parvovirus uses clathrin-mediated endocytosis for cell entry. J. Gen. Virol. 91:3032-3041.
21. Filippone C, et al. 2010. Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One 5:e9496. doi:10.1371/journal.pone.0009496.
22. Gigler A, et al. 1999. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J. Virol. 73:1974-1979.
23. Guan W, et al. 2008. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J. Virol. 82:9951-9963.
24. Hansen J, Qing K, Srivastava A. 2001. Infection of purified nuclei by adeno-associated virus 2. Mol. Ther. 4:289-296.
25. Harbison CE, Chiorini JA, Parrish CR. 2008. The parvovirus capsid odyssey: from the cell surface to the nucleus. Trends Microbiol. 16:208-214.
26. Hopkins CR, Trowbridge LS. 1983. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells J. Cell Biol. 97:508-521.
27. Kankaanpää P, Pahajoki K, Marjomäki V, Heino J, White D. 2006. BioImageXD. New open source free software for the processing, analysis and visualization of multidimensional microscopic images. Microsc. Today 14:12-16.
28. Khalil IA, Kogure K, Akita H, Harashima H. 2006. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58:32-45.
29. Le PU, Nabi IR. 2003. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116:1059-1071.
30. Leruez M, et al. 1994. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization. J. Gen. Virol. 75:1475-1478.
31. Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science 327:46-50.
32. Luthman H, Magnusson G. 1983. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11:1295-1308.
33. Lux K, et al. 2005. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. J. Virol. 79:11776-11787.
34. Macdonald JL, Pike LJ. 2005. A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46:1061-1067.
35. Mani B, et al. 2006. Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome. J. Virol. 80:1015-1024.
36. Maxfield FR. 1982. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J. Cell Biol. 95:676-681.
37. Mellman I, Fuchs R, Helenius A. 1986. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55:663-700.
38. Morrow IC, et al. 2002. Flotillin-1/reggie-2 traffics to surface raft domains via a novel Golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation. J. Biol. Chem. 277:48834-48841.
39. Mousavi SA, Malerød L, Berg T, Kjeken R. 2004. Clathrin-dependent endocytosis. Biochem. J. 377:1-16.
40. Munakata Y, et al. 2005. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:3449-3456.
41. Parker JS, Parrish CR. 2000. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 74:1919-1930.
42. Parrish CR. 2010. Structures and functions of parvovirus capsids and the process of cell infection. Curr. Top. Microbiol. Immunol. 343:149-176.
43. Prchla E, Plank C, Wagner E, Blaas D, Fuchs R. 1995. Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2. J. Cell Biol. 131:111-123.
44. Ros C, Burckhardt CJ, Kempf C. 2002. Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J. Virol. 76:12634-12645.
45. Ros C, Gerber M, Kempf C. 2006. Conformational changes in the VP1-unique region of native human parvovirus B19V lead to exposure of internal sequences playing a role in virus neutralization and infectivity. J. Virol. 80:12017-12024.
46. Rothberg KG, Ying YS, Kamen BA, Anderson RG. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111:2931-2938.
47. Rothberg KG, et al. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
48. Servant-Delmas A, Lefrère JJ, Morinet F, Pillet S. 2010. Advances in human B19 erythrovirus biology. J. Virol. 84:9658-9665.
49. Servey JT, Reamy BV, Hodge J. 2007. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician 75:373-376.
50. Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA. 2006. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 80:11040-11054.
51. St Amand J, Astell CR. 1993. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 192:121-131.
52. Suikkanen S, Antila M, Jaatinen A, Vihinen-Ranta M, Vuento M. 2003. Release of canine parvovirus from endocytic vesicles. Virology 316:267-280.
53. Suzuki T, Suzuki Y. 2006. Virus infection and lipid rafts. Biol. Pharm. Bull. 29:1538-1541.
54. Vendeville A, et al. 2009. Densovirus infectious pathway requires clathrin mediated endocytosis followed by trafficking to the nucleus. J. Virol. 83:4678-4689.
55. Vieira FS, Correa G, Einicker-Lamas M, Coutinho-Silva R. 2010. Host-cell lipid rafts: a safe door for micro-organisms? Biol. Cell 102:391-407.
56. Vihinen-Ranta M, Yuan W, Parrish CR. 2000. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J. Virol. 74:4853-4859.
57. Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR. 2002. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J. Virol. 76:1884-1891.
58. Weigel-Kelley KA, Yoder MC, Srivastava A. 2001. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J. Virol. 75:4110-4116.
59. 1 integrin for viral entry. Blood 102:3927-3933.
60. + erythroid progenitors are highly permissive to human parvovirus B19 replication. J. Virol. 82:2470-2476.
61. Xiao W, Warrington KH, Jr, Hearing P, Hughes J, Muzyczka N. 2002. Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J. Virol. 76:11505-11517.
62. Yuan C, Johnston LJ. 2000. Distribution of ganglioside GM1 in L-α-dipalmitoylphosphatidylcholine/cholesterol monolayers: a model for lipid rafts. Biophys. J. 79:2768-2781.
63. Zádori Z, et al. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1:291-302.
64. Zhi N, et al. 2006. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrate essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J. Virol. 80:5941-5950.